ivWatch

ivWatch, LLC - a medical device and biosensor company focused on improving patient safety through early detection of IV infiltrations and extravasations.

[ivWatch @ivWatch]

ivWatch is redefining IV therapy safety. The world’s only continuous IV monitoring system is clinically proven to detect infiltration and extravasation events before visible signs appear, ivWatch helps prevent severe IV harm before it happens.

Backed by decades of research and clinical validation, ivWatch continuously monitors IV site integrity in high-risk care settings. IV therapy is one of the most common procedures in healthcare, yet studies show up to 50% of IVs fail before treatment is complete, resulting in pain, tissue injury, prolonged hospital stays, and higher costs.

Using a non-invasive sensor technology and a predictive algorithm, ivWatch empowers clinical teams to intervene early, improve patient outcomes, reduce liability, and drive cost savings—setting a new standard of care for IV therapy.

Our mission is bold: STOP IV HARM.

Watch the video and schedule a demo to see ivWatch in action: https://t.co/U7UpAQjHwj

#IVSafety #PatientSafety #HealthcareInnovation #MedTech #NursingTechnology #InfiltrationDetection #ContinuousMonitoring
#ClinicalExcellence #HospitalSafety #VascularAccess
#InfusionTherapy #AvoidableHarm

[ivWatch @ivWatch]

Improving IV safety takes more than new technology—it requires a shift in how teams approach infusion care. Real progress happens when innovation is paired with clinician education, collaboration, and a shared commitment to patient safety.

By working alongside clinical teams, we’re helping address preventable IV infiltration and extravasation events through a proven, proactive approach that supports earlier intervention, greater clinician confidence, and better outcomes.

This is about building safer systems, empowering nurses, and raising the standard of IV therapy—together.

#ivWatch #PatientSafety #IVTherapy #InfusionCare #NurseDriven #ClinicalSupport #HealthcareExcellence

[ivWatch @ivWatch]

Fresh energy out of the Emirates Critical Care Conference in Dubai, where IV safety and innovation took center stage.

It's energizing to see critical care teams leaning into proactive strategies to reduce extravasation risk and advance safer peripheral vasopressor practices.

The focus on earlier detection and continuous monitoring is gaining real traction—and driving meaningful progress in patient safety.

More to come as this momentum builds.

[ivWatch @ivWatch]

Join our movement to end avoidable IV harm.

ivWatch is advancing IV therapy safety worldwide by partnering with hospitals and healthcare leaders that are evangelists for change. We’re bridging clinical practice with smarter technology to advance patient safety priorities.

Each interaction, each visit, and each implementation of our product moves us closer to a shared goal: empowering clinicians, improving outcomes, and raising the bar for infusion care no matter where in the world IV therapy is needed.

#IVExtravasation #IVTherapy #PatientSafety #InfusionSafety #HealthcareTechnology

[ivWatch @ivWatch]

We’re proud to work alongside healthcare teams who are redefining what’s possible in IV therapy. Through early detection technology and real-time data, clinicians are empowered to identify risks sooner, take action and deliver safer care.

#IVInnovation #PatientSafety #ClinicalExcellence #IVTherapy #ivWatchOnTheRoad

[ivWatch @ivWatch]

Normal saline may be classified as low risk — but a missed infiltration can still lead to devastating patient harm.

Complications can escalate quickly—compartment syndrome requiring an emergency fasciotomy, nerve ischemia and compression leading to sensory or motor deficits, and even skin necrosis requiring surgical debridement.

Our latest article explores:
• Why saline infiltration remains underrecognized
• The mechanism behind serious tissue injury
• Which patient populations are most vulnerable
• Why delayed detection is the real systems problem
• Evidence-based prevention and monitoring strategies

Early detection matters — even for “low-risk” fluids.

Read more: https://t.co/hB6ygRwtMj

#PatientSafety #IVTherapy #VascularAccess #Salineinfiltration
#SodiumchlorideIV #InfusionNursing #HealthcareInnovation

[ivWatch @ivWatch]

It has never been more evident that the current standard of care in IV therapy is falling short. As IV infiltration rates continue to rise, relying on visible injury before taking action remains an outdated practice.

In today’s clinical environment, technology must evolve to meet the urgency of patient safety. That’s why we developed ivWatch—a clinically validated, continuous monitoring solution that evaluates IV sites five times per second, identifying risk at the earliest onset of an IV injury, before visible signs appear.

Learn how ivWatch technology is transforming IV care and helping clinicians detect infiltration sooner: https://t.co/V9CVgdOQdm

#IVTherapy #IVSafety #ExtravasationAwareness #VascularAccess #PatientSafety

[ivWatch @ivWatch]

In the operating room, IVs go unchecked for hours. This is when patients are their most vulnerable.

In these moments, early detection is critical. Relying solely on intermittent checks can leave teams without visibility and create harm over hours before identified. That’s scary for physicians, clinicians and patients alike. This harm is avoidable.
Continuous IV site monitoring gives surgical and anesthesia teams greater awareness—helping identify issues sooner and safeguard patients throughout the procedure.

Early detection plays an important role in protecting patients during surgery—particularly when IV complications are difficult to see in real time. Learn more about how continuous IV monitoring supports patient safety: https://t.co/YF3A1BH2L7

#PatientSafety #SurgerySafety #Anesthesia #IVSafety #ClinicalReliability

[ivWatch @ivWatch]

The time for change is now.

We must evolve beyond the age-old practice of 'trust the flush'. It is no longer sufficient to rely on saline flushes and blood return to verify proper IV placement, as they can miss early signs of infiltration, exposing patients to the dangers of extravasations.

It’s important to understand why “trusting the flush” could set you up for failure.

Discover other factors that contribute to IV infiltration and extravasation by reading our full article: https://t.co/oCwFHBiLjT

#patientharm #ivtherapy #ivextravasation #ivwatch

[ivWatch @ivWatch]

Working alongside NHS care teams means focusing on what matters most: shared learning, practical support, and safer care at the bedside.

Through collaboration and hands‑on education, ivWatch supports a more proactive approach to IV therapy—helping teams recognize risk earlier and protect patients from avoidable harm.

Proud to partner with teams committed to raising standards in IV safety.

#ivWatch #PatientSafety #IVTherapy #NHS #InfusionCare

[ivWatch @ivWatch]

IV injuries aren’t just clinical events—they’re multi‑million dollar liabilities hiding in plain sight.

Up to 50% of peripheral IVs fail, yet the real cost of infiltration injuries is rarely measured. New data shows hospitals could unlock $5M–$13M+ in annual margin impact—simply by enhancing periodic manual checks with continuous monitoring technology.

This isn’t incremental. It’s a 93% reduction in injury severity and a 7x–14x ROI.

Read how leading hospitals are turning unseen risk into measurable value: https://t.co/qEP6xJ9d4Y
#PatientSafety #HealthcareLeadership #HospitalFinance #NursingLeadership #ROI

[ivWatch @ivWatch]

If you do not think IV extravasations are an issue in your hospital, you are wrong. Make a choice every day to be a part of the solution to help solve the global IV epidemic.

It is time to enhance your clinical IV assessments with continuous patient monitoring.

#IVTherapy #PatientSafety #IVMonitoring
#IVExtravasation #IVInfiltration

[ivWatch @ivWatch]

This week, we proudly celebrate the nurses —who show up every day with skill, compassion, and unwavering dedication.

You are the frontline of patient safety.

You are advocates, problem-solvers, and trusted partners in care. You are the difference.

Thank you for the impact you make, the vigilance you bring, and the lives you protect—every shift, every patient, every day.

We see you. We value you. We celebrate you.

#NationalNursesWeek #ThankYouNurses #NurseLife #PatientSafety #ivWatch #NursesMakeTheDifference

[ivWatch @ivWatch]

But these are not reasons to turn a blind eye. IV sites are frequently draped during procedures, overlooked during shift changes, or deprioritized when workloads increase.

When routine checks are delayed or missed for hours, even “just saline” can escalate into serious complications—such as compartment syndrome, requiring invasive intervention like fasciotomy.

Every medication. Every infusion. Every patient.

All IVs carry risk and demand continuous site assessment.

Learn how ivWatch technology provides continuous IV site monitoring to help clinicians detect infiltration earlier—before visible injury occurs: https://t.co/AfPeBZadck

Read more about Lucas' story: https://t.co/1kc6ne2Ugh

#IVInfiltration #IVSafety #PatientSafety #IVComplications

[ivWatch @ivWatch]

Reactive IV care is no longer enough.

Despite best intentions, IV extravasation continues to result in avoidable patient harm—revealing critical gaps in early detection, infusion protocols, and clinical preparedness.

It’s time to rethink infusion therapy safety by:
• Adopting proactive technology that identifies IV risk earlier
• Aligning IV protocols with today’s patient complexity
• Equipping clinicians with education that meets modern standards of care

Preventing IV extravasation requires more than awareness. It demands leadership, real‑time insight, and action.

The future of IV safety needs to start now to prevent avoidable patient harm.

#IVExtravasation #IVTherapy #PatientSafety #InfusionSafety #HealthcareTechnology

[ivWatch @ivWatch]

Increased vein porosity is usually a result of inflammation in the vein and can be seen with certain medications infusing such as vasopressors.

The increased space between the cells in the vein wall can allow fluid to leak out and pool in the surrounding tissue.

The Challenge:
· Fluid leakage is partial and will develop more slowly, so physical signs may not appear until later stages of the infiltration process.
· Because the catheter is still secured inside of the vein, flushing with normal saline, or drawing for blood return will likely still look normal.

#IVInfiltration #VeinPorosity #VascularAccess #Vasopressors #IVComplications #ExtravasationAwareness #ClinicalEducation

[ivWatch @ivWatch]

Our work to prevent IV harm is grounded in partnership, clinical insight, and a shared commitment to safer care.

From early conversations with healthcare teams, to in‑depth clinical evaluations that surface real challenges, to supporting broader adoption across services—we stay closely involved every step of the way. By combining IV therapy expertise with proactive support, we help teams identify risk sooner and take meaningful action to protect patients.

Preventing severe IV injury starts before harm occurs—and that’s where being part of the solution truly matters.

Learn how a proactive approach can strengthen IV safety across your organization.
#ivWatch #IVTherapy #PatientSafety #NurseLedCare #PreventableHarm #IVExtravasation

[ivWatch @ivWatch]

Honored to see Maya Aquino-Guerrero, from NHS Supply Chain and NIVAS Board Member, presenting her poster on ivWatch technology at the WoCoVA 9th World Congress on Vascular Access.

Maya’s work reflects a clear commitment to advancing vascular access practice through evidence, innovation, and a strong focus on patient safety.

Presenting at a global forum like WoCoVA highlights the importance of early IV complication detection and the role technology can play in strengthening infusion safety—particularly in high‑risk and high‑acuity settings.

Grateful for clinical leaders who continue to champion safer IV therapy, contribute to the global vascular access community, and help push the conversation forward through research, collaboration, and real‑world experience.

Congratulations on this important contribution.

#PatientSafety #VascularAccess #IVTherapy #WoCoVA #InfusionSafety #ivWatch

[ivWatch @ivWatch]

Peripheral IV therapy ranks among the most common procedures in NHS hospitals, yet infiltration and extravasation remain significantly under‑recognized contributors to patient harm.

Conventional visual and manual assessments frequently miss early tissue changes, particularly when IV sites are obscured or patients cannot communicate pain, leading to adverse events.

Clinical evaluations referenced by NHS Supply Chain show how continuous monitoring technologies like ivWatch can support earlier detection, reduce harm severity, and safeguard high‑risk infusions across adult and pediatric care.

ivWatch’s growing availability through NHS Supply Chain helps make IV harm visible—and preventable.

Read more in our latest press release: https://t.co/ihhfxhPuH2

#IVSafety #PatientSafety #VascularAccess #NHSInnovation #InfusionTherapy

[ivWatch @ivWatch]

A lot can happen in the 59 minutes between IV checks.

Hourly assessments help—but IV infiltration and extravasation events don’t wait on a schedule. By the time visible signs appear, damage may already be well underway.

Continuous monitoring adds what traditional methods can’t: constant vigilance.

Earlier detection. Faster intervention. Better outcomes.
That’s why continuous monitoring must become a standard in IV therapy care.

Join the movement to help prevent avoidable harm.

#IVSafety #PatientSafety #InfusionTherapy #VascularAccess #ClinicalExcellence

[ivWatch @ivWatch]

Clinicians are advised to monitor chemotherapy infusions every 5 to 10 minutes due to the severe and potentially life-threatening harm that can occur from an extravasation.

But how often is this reality?

With continuous monitoring of 5 times per second, we offer patients and caregivers peace of mind even before the first initial check. Help give these patients one less thing to worry about and be an advocate towards detecting the inevitable.

Read more: https://t.co/gVCsfw4ApA

#IVTherapy #PatientSafety #HealthcareInnovation #IVMonitoring
#IVExtravasation #IVInfiltration